The pharmaceutical industry churns out dozens of new drugs and biological products every year. Most are small tweaks to something previously approved by the FDA--so called "me-too" alternatives, which are different formulations of a drug, or the exact same molecule used for another medical condition. But 2018 saw the birth of a select few players […]
The pharmaceutical industry churns out dozens of new drugs and biological products every year. Most are small tweaks to something previously approved by the FDA--so called "me-too" alternatives, which are different formulations of a drug, or the exact same molecule used for another medical condition. But 2018 saw the birth of a select few players […]
Share this Article
Recommended